Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Influence of the foveal curvature on myopic macular complications.

Park UC, Ma DJ, Ghim WH, Yu HG.

Sci Rep. 2019 Nov 15;9(1):16936. doi: 10.1038/s41598-019-53443-4.

2.

A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.

Chintakuntlawar AV, Yin J, Foote RL, Kasperbauer JL, Rivera M, Asmus E, Garces NI, Janus JR, Liu M, Ma DJ, Moore EJ, Morris JC 3rd, Neben-Wittich M, Price DL, Price KA, Ryder M, Van Abel KM, Hilger C, Samb E, Bible KC.

Thyroid. 2019 Nov;29(11):1615-1622. doi: 10.1089/thy.2019.0086.

PMID:
31595822
3.

Reply to A.S. Garden.

Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller RC, Shiraishi S, Mutter RW, Corbin KS, Park SS, Foote RL.

J Clin Oncol. 2019 Sep 26:JCO1902144. doi: 10.1200/JCO.19.02144. [Epub ahead of print] No abstract available.

PMID:
31557088
4.

Derivation and applications of human hepatocyte-like cells.

Li S, Huang SQ, Zhao YX, Ding YJ, Ma DJ, Ding QR.

World J Stem Cells. 2019 Aug 26;11(8):535-547. doi: 10.4252/wjsc.v11.i8.535. Review.

5.

Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones.

Tew BY, Legendre C, Schroeder MA, Triche T, Gooden GC, Huang Y, Butry L, Ma DJ, Johnson K, Martinez RA, Pierobon M, Petricoin EF, O'Shaughnessy J, Osborne C, Tapia C, Buckley DN, Glen J, Bernstein M, Sarkaria JN, Toms SA, Salhia B.

Neuro Oncol. 2019 Aug 21. pii: noz137. doi: 10.1093/neuonc/noz137. [Epub ahead of print]

PMID:
31433055
6.

Magnetic Iron Oxide Nanoparticle Labeling of Photoreceptor Precursors for Magnetic Resonance Imaging.

Ma DJ, Lim MS, Park UC, Park JB, Ji SY, Yu HG.

Tissue Eng Part C Methods. 2019 Sep;25(9):532-542. doi: 10.1089/ten.TEC.2019.0136. Epub 2019 Sep 11.

PMID:
31418341
7.

Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.

Van Abel KM, Quick MH, Graner DE, Lohse CM, Price DL, Price KAR, Ma DJ, Moore EJ.

Am J Otolaryngol. 2019 Sep - Oct;40(5):729-734. doi: 10.1016/j.amjoto.2019.07.003. Epub 2019 Jul 3.

PMID:
31303455
8.

Identifying the Most Costly Patients in Radiation Oncology and Predicting the Top Spenders.

Waddle MR, Kaleem TA, Stross WC, Malouff TD, White L, Li Z, Naessens J, Spaulding A, Aljabri D, Ma DJ, Keole S, Miller RC.

J Oncol Pract. 2019 Aug;15(8):e704-e716. doi: 10.1200/JOP.18.00627. Epub 2019 Jun 17.

PMID:
31206338
9.

A RANDOMIZED PAIRED-EYE TRIAL OF INTRAVITREAL DEXAMETHASONE IMPLANT FOR CYSTOID MACULAR EDEMA IN RETINITIS PIGMENTOSA.

Park UC, Park JH, Ma DJ, Cho IH, Oh BL, Yu HG.

Retina. 2019 Jun 3. doi: 10.1097/IAE.0000000000002589. [Epub ahead of print]

PMID:
31166248
10.

Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma.

Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Foster NR, Ginos B, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Olsen KD, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller R, Shiraishi S, Foote RL.

J Clin Oncol. 2019 Aug 1;37(22):1909-1918. doi: 10.1200/JCO.19.00463. Epub 2019 Jun 4.

PMID:
31163012
11.

Correlations of the ZEB1 expression with the incidence and prognosis of non-small cell lung cancer.

Ma DJ, Liu HS, Li SQ, Qin YZ, He J, Li L, Cui YS.

Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1528-1535. doi: 10.26355/eurrev_201902_17111.

12.

c.1439delA frameshift deletion mutation in familial adenomatous polyposis.

Ma DJ, Wang BS, Yue JB, Li ZJ, Sun YL.

Onco Targets Ther. 2018 Dec 11;11:8987-8993. doi: 10.2147/OTT.S183153. eCollection 2018.

13.

Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults.

Gamez ME, Kraus R, Hinni ML, Moore EJ, Ma DJ, Ko SJ, Rwigema JCM, McGee LA, Halyard MY, Buras MR, Foote RL, Patel SH.

Oral Oncol. 2018 Dec;87:43-48. doi: 10.1016/j.oraloncology.2018.10.014. Epub 2018 Oct 22.

PMID:
30527242
14.

Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy: Association with pathologic complete response.

Dong JM, Wang HX, Zhong XF, Xu K, Bian J, Feng Y, Chen L, Zhang L, Wang X, Ma DJ, Wang B.

Medicine (Baltimore). 2018 Oct;97(43):e12965. doi: 10.1097/MD.0000000000012965.

15.

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.

Sio TT, Atherton PJ, Pederson LD, Zhen WK, Mutter RW, Garces YI, Ma DJ, Leenstra JL, Rwigema JM, Dakhil S, Bearden JD, van der Veen SJ, Ganti AK, Schild SE, Miller RC.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):686-696. doi: 10.1016/j.ijrobp.2018.10.035. Epub 2018 Nov 2.

16.

Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy.

Ma DJ, Park UC, Kim ET, Yu HG.

PLoS One. 2018 Aug 27;13(8):e0202930. doi: 10.1371/journal.pone.0202930. eCollection 2018.

17.

Orbital Apex Lesions: A Diagnostic and Therapeutic Challenge.

Cho SW, Lee WW, Ma DJ, Kim JH, Han DH, Kim HJ, Kim DY, Kim SJ, Khwarg SI, Kim SM, Paek SH, Rhee CS, Lee CH, Hwang PH, Won TB.

J Neurol Surg B Skull Base. 2018 Aug;79(4):386-393. doi: 10.1055/s-0037-1612616. Epub 2017 Dec 13.

18.

Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain Barrier.

Kim M, Ma DJ, Calligaris D, Zhang S, Feathers RW, Vaubel RA, Meaux I, Mladek AC, Parrish KE, Jin F, Barriere C, Debussche L, Watters J, Tian S, Decker PA, Eckel-Passow JE, Kitange GJ, Johnson AJ, Parney IF, Anastasiadis PZ, Agar NYR, Elmquist WF, Sarkaria JN.

Mol Cancer Ther. 2018 Sep;17(9):1893-1901. doi: 10.1158/1535-7163.MCT-17-0600. Epub 2018 Jul 3.

19.

Magnitude of benefit for adjuvant radiotherapy following minimally invasive surgery in intermediate to high risk HPV-positive oropharyngeal squamous cell carcinoma.

Pasalic D, Funk RK, García JJ, Price DL, Price KA, Harmsen WS, Patel SH, Young GD, Foote RL, Moore EJ, Ma DJ.

Oral Oncol. 2018 Jul;82:181-186. doi: 10.1016/j.oraloncology.2018.05.026. Epub 2018 Jun 6.

PMID:
29909895
20.

Synthesis, bioactivity and mode of action of 5A 5B 6C tricyclic spirolactones as novel antiviral lead compounds.

Zhu YJ, Wu QF, Fan ZJ, Huo JQ, Zhang JL, Zhao B, Lai C, Qian XL, Ma DJ, Wang DW.

Pest Manag Sci. 2019 Jan;75(1):292-301. doi: 10.1002/ps.5115. Epub 2018 Sep 4.

PMID:
29885056
21.

In Reply to Garden.

Routman DM, Foote RL, Ma DJ, Patel SH, Hinni ML.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1296-1297. doi: 10.1016/j.ijrobp.2018.01.007. No abstract available.

PMID:
29722671
22.

Data collection of patient outcomes: one institution's experience.

Whitaker TJ, Mayo CS, Ma DJ, Haddock MG, Miller RC, Corbin KS, Neben-Wittich M, Leenstra JL, Laack NN, Fatyga M, Schild SE, Vargas CE, Tzou KS, Hadley AR, Buskirk SJ, Foote RL.

J Radiat Res. 2018 Mar 1;59(suppl_1):i19-i24. doi: 10.1093/jrr/rry013.

23.

Biological Model for Predicting Toxicity in Head and Neck Cancer Patients Receiving Proton Therapy.

Fossum CC, Beltran CJ, Whitaker TJ, Ma DJ, Foote RL.

Int J Part Ther. 2017 Fall;4(2):18-25. doi: 10.14338/IJPT-17-00015. Epub 2017 Dec 28.

24.

Placental transmogrification of the lung: Case report and systematic review of the literature.

Ma DJ, Liu HS, Li SQ, Zhou XY, Cui YS, Wu HW, Zhou WX.

Medicine (Baltimore). 2017 Sep;96(35):e7733. doi: 10.1097/MD.0000000000007733. Review.

25.

Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma.

Laramy JK, Kim M, Gupta SK, Parrish KE, Zhang S, Bakken KK, Carlson BL, Mladek AC, Ma DJ, Sarkaria JN, Elmquist WF.

J Pharmacol Exp Ther. 2017 Nov;363(2):136-147. doi: 10.1124/jpet.117.243477. Epub 2017 Aug 28.

26.

Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional Review.

Routman DM, Funk RK, Tangsriwong K, Lin A, Keeney MG, García JJ, Zarka MA, Lewis JT, Stoddard DG, Moore EJ, Day CN, Zhai Q, Price KA, Lukens JN, Swisher-McClure S, Weinstein GS, O'Malley BW Jr, Foote RL, Ma DJ.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):938-946. doi: 10.1016/j.ijrobp.2017.06.2453. Epub 2017 Jun 28. Erratum in: Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1304.

PMID:
28847412
27.

Characteristics and long-term outcomes of head and neck squamous cell carcinoma after solid organ transplantation.

Alsidawi S, Price KA, Chintakuntlawar AV, Westin GF, Garcia JJ, Ma DJ, Okuno SH.

Oral Oncol. 2017 Sep;72:104-109. doi: 10.1016/j.oraloncology.2017.07.010. Epub 2017 Jul 17.

PMID:
28797445
28.

Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis.

Shin YU, Shin JY, Ma DJ, Cho H, Yu HG.

J Ophthalmol. 2017;2017:5946240. doi: 10.1155/2017/5946240. Epub 2017 Mar 30.

29.

Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.

Graffeo CS, Leeper HE, Perry A, Uhm JH, Lachance DJ, Brown PD, Ma DJ, Van Gompel JJ, Giannini C, Johnson DR, Raghunathan A.

World Neurosurg. 2017 Jul;103:655-663. doi: 10.1016/j.wneu.2017.04.095. Epub 2017 Apr 24.

PMID:
28450233
30.

Risk of Delayed Lymph Node Metastasis in Clinically N0 Esthesioneuroblastoma.

Peacock JG, Harmsen WS, Link MJ, Van Gompel JJ, Giannini C, Olsen KD, Garces YI, Neben Wittich MA, Ma DJ, Park SS, Foote RL.

J Neurol Surg B Skull Base. 2017 Feb;78(1):68-74. doi: 10.1055/s-0036-1584904. Epub 2016 Jul 6.

31.
32.

Stability analysis of Rayleigh-Bénard convection in a cylinder with internal heat generation.

Wang BF, Zhou L, Wan ZH, Ma DJ, Sun DJ.

Phys Rev E. 2016 Jul;94(1-1):013108. doi: 10.1103/PhysRevE.94.013108. Epub 2016 Jul 14.

PMID:
27575218
34.

Surgical responses and outcomes of bilateral lateral rectus recession in exotropia with cerebral palsy.

Ma DJ, Yang HK, Hwang JM.

Acta Ophthalmol. 2017 May;95(3):e179-e184. doi: 10.1111/aos.13158. Epub 2016 Jul 16.

35.

Clinically Applicable Monte Carlo-based Biological Dose Optimization for the Treatment of Head and Neck Cancers With Spot-Scanning Proton Therapy.

Wan Chan Tseung HS, Ma J, Kreofsky CR, Ma DJ, Beltran C.

Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1535-1543. doi: 10.1016/j.ijrobp.2016.03.041. Epub 2016 Apr 6.

PMID:
27325476
36.

Ectopic adrenocorticotropic hormone syndrome caused by neuroendocrine tumors of the thymus: 30-year experience with 16 patients at a single institute in the People's Republic of China.

Chen YY, Li SQ, Liu HS, Qin YZ, Li L, Huang C, Bi YL, Meng YX, He J, Zhou XY, Ma DJ.

Onco Targets Ther. 2016 Apr 26;9:2193-201. doi: 10.2147/OTT.S100585. eCollection 2016.

37.

Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review.

Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Park SS, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):e117-26. doi: 10.1016/j.prro.2015.11.001. Epub 2016 Jan 26. Review.

PMID:
26825250
38.

Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma.

Funk RK, Moore EJ, García JJ, Harmsen WS, Stoddard DG, Vencio EF, Foote RL, Price KA, Ma DJ.

Head Neck. 2016 Apr;38 Suppl 1:E1674-9. doi: 10.1002/hed.24298. Epub 2015 Dec 15.

PMID:
26667985
39.

Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases.

Vaidhyanathan S, Wilken-Resman B, Ma DJ, Parrish KE, Mittapalli RK, Carlson BL, Sarkaria JN, Elmquist WF.

J Pharmacol Exp Ther. 2016 Feb;356(2):251-9. doi: 10.1124/jpet.115.229393. Epub 2015 Nov 24.

40.

Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules.

Owen D, Olivier KR, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI.

Radiat Oncol. 2015 Feb 18;10:43. doi: 10.1186/s13014-015-0340-9.

42.

Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung.

Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI.

Front Oncol. 2015 Jan 14;4:376. doi: 10.3389/fonc.2014.00376. eCollection 2014.

43.

MARQUIS: a multiplex method for absolute quantification of peptides and posttranslational modifications.

Curran TG, Zhang Y, Ma DJ, Sarkaria JN, White FM.

Nat Commun. 2015 Jan 12;6:5924. doi: 10.1038/ncomms6924.

44.

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.

Ma DJ, Galanis E, Anderson SK, Schiff D, Kaufmann TJ, Peller PJ, Giannini C, Brown PD, Uhm JH, McGraw S, Jaeckle KA, Flynn PJ, Ligon KL, Buckner JC, Sarkaria JN.

Neuro Oncol. 2015 Sep;17(9):1261-9. doi: 10.1093/neuonc/nou328. Epub 2014 Dec 18.

45.

Multidisciplinary medical simulation: a novel educational approach to preparing radiation oncology residents for oncologic emergent on-call treatments.

Brown LC, Laack TA, Ma DJ, Olivier KR, Laack NN.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):705-6. doi: 10.1016/j.ijrobp.2014.06.053. Epub 2014 Sep 26. No abstract available.

PMID:
25304952
46.
47.

Predicting 1-month response of macular edema to intravitreal bevacizumab from 1-hour response.

Ma DJ, Park KH, Woo SJ.

Can J Ophthalmol. 2014 Jun;49(3):267-72. doi: 10.1016/j.jcjo.2014.03.007.

PMID:
24862773
48.

Rayleigh-Bénard convection in a vertical annular container near the convection threshold.

Wang BF, Wan ZH, Ma DJ, Sun DJ.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Apr;89(4):043014. Epub 2014 Apr 18.

PMID:
24827339
49.

Endothelial dysfunction in patients with primary aldosteronism: a biomarker of target organ damage.

Liu G, Yin GS, Tang JY, Ma DJ, Ru J, Huang XH.

J Hum Hypertens. 2014 Dec;28(12):711-5. doi: 10.1038/jhh.2014.11. Epub 2014 Feb 20.

PMID:
24553636
50.

Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma.

Geiger JL, Lazim AF, Walsh FJ, Foote RL, Moore EJ, Okuno SH, Olsen KD, Kasperbauer JL, Price DL, Garces YI, Ma DJ, Neben-Wittich MA, Molina JR, Garcia JJ, Price KA.

Oral Oncol. 2014 Apr;50(4):311-8. doi: 10.1016/j.oraloncology.2014.01.001. Epub 2014 Jan 24.

PMID:
24467937

Supplemental Content

Support Center